Strategic Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Sell
4,188
-6,372
-60% -$2.78M 0.36% 51
2026
Q1
$4.87M Sell
10,560
-404
-4% -$204K 0.81% 35
2025
Q4
$6.21M Buy
10,964
+567
+5% +$302K 0.97% 28
2025
Q3
$4.65M Buy
10,397
+4,031
+63% +$1.93M 0.75% 29
2025
Q2
$3.46M Buy
6,366
+2,471
+63% +$1.29M 0.68% 30
2025
Q1
$1.93M Buy
3,895
+3,261
+514% +$1.8M 0.37% 58
2024
Q4
$331K Buy
634
+10
+2% +$5.21K 0.06% 163
2024
Q3
$307K Hold
624
0.06% 176
2024
Q2
$278K Buy
624
+5
+0.8% +$1.99K 0.05% 176
2024
Q1
$247K Sell
619
-12
-2% -$4.53K 0.05% 182
2023
Q4
$213K Buy
+631
New +$188K 0.04% 191
2023
Q3
Sell
-592
Closed -$202K 199
2023
Q2
$202K Buy
+592
New +$179K 0.04% 184
2022
Q2
Sell
-903
Closed -$272K 197
2022
Q1
$272K Sell
903
-5,526
-86% -$1.61M 0.05% 166
2021
Q4
$2.31M Buy
+6,429
New +$2.21M 0.33% 70

Other funds holding ISRG

Strategic Advisors's ISRG Position: Q2 2026 in Review

Strategic Advisors reduced its Intuitive Surgical (ISRG) stake by 60% in Q2 2026, selling an estimated $2.78M and leaving 4,188 shares worth $1.67M. The position accounts for 0.36% of the portfolio, ranked #51.

Strategic Advisors first reported a position in ISRG in Q4 2021 and has held it in 14 quarters since. The position peaked at $6.21M in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Strategic Advisors held 4,188 shares of Intuitive Surgical worth $1.67M as of Q2 2026.
  • Strategic Advisors sold 6,372 Intuitive Surgical shares in Q2 2026, an estimated $2.78M.
  • Intuitive Surgical made up 0.36% of Strategic Advisors's portfolio in Q2 2026, its #51 holding.
  • Strategic Advisors first reported a position in Intuitive Surgical in Q4 2021 and has held it in 14 quarters since.
  • Strategic Advisors's Intuitive Surgical position peaked at $6.21M in Q4 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.